Coping style &amp; stressor susceptibility:Neuroendocrine and neurochemical studies with genetically selected mouse lines by Veenema, Alexandra Hendrika
  
 University of Groningen
Coping style & stressor susceptibility
Veenema, Alexandra Hendrika
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2003
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Veenema, A. H. (2003). Coping style & stressor susceptibility: Neuroendocrine and neurochemical studies
with genetically selected mouse lines. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019






8        Chapter 1 









2. The stress response 
    2.1. The HPA axis 
2.1.1. Description and function of the HPA axis 
2.1.2. Mechanism of corticosteroid action 
2.1.3. HPA dysregulation in depression  
   2.2. The brain serotonin system 
3.1.1. Description and function of the serotonin system 
3.1.2. Serotonin dysregulation in depression 
   2.3. Interactions between the HPA and serotonin systems 
 
 
3. Individual susceptibility to stressors  
    3.1. Genetically selected mouse lines 
 
 
4. Aim of the thesis 
    4.1. Experimental approach 




General introduction        9 
1. Introduction 
 
Life requires organisms to adapt to changing environmental demands. These 
emotionally and/or physically adaptations are in general referred to as the stress 
response, and involve behavioural, neuroendocrine and neurochemical changes. 
Failure of proper adaptation to the stressor will result in sustained over-activation 
of several stress systems and this may lead to the development of stress-related 
psychopathologies such as anxiety and depression. The way animals, including 
humans, cope with stressful events shows, however, a considerable individual 
variation, which may underlie a differential vulnerability to the development of 
stress-related pathologies. Why some individuals are more likely to suffer from 
stress-related pathologies than others under seemingly similar conditions is still an 
unresolved phenomenon. 
 
This thesis focused on further analysis of individual differences in stress 
reactivity. The objective was to find causal factors underlying individual 
differences in susceptibility to stress and stress-related psychopathologies. These 
individual differences will be studied in two lines of mice, that show distinctly 
different behavioural strategies towards environmental stimuli. It is hypothesized 
that this difference in behavioural coping style has, as consequence, a differential 
susceptibility to stressors. The focus will be on two systems involved in stress 
adaptation: i.e. the hypothalamic-pituitary-adrenal (HPA) axis and the serotonergic 
(5-hydroxytryptamine, 5-HT) system. In the following paragraphs the role of the 
HPA axis, the 5-HT system in stress and stress-related psychopathologies will be 




2. The stress response 
 
Stress is defined as a state of threatened homeostasis, which can be of physical 
and/or psychological nature. In particular psychological and social stimuli were 
found to be powerful ‘stressors’ (Mason, 1971; Koolhaas et al., 1997). The stress 
response is an adaptive compensatory response of the organism to sustain 
homeostasis. The concept of stress was first described by Selye (1936, 1950). He 
was intrigued by the non-specificity of the bodies response to stress. Indeed, any 
perceived stressor will lead to the activation of the autonomic nervous system and 
of the Hypothalamus-Pituitary-Adrenal (HPA) axis. However, the characteristics of 
the stressor (such as type, duration, predictability and controllability of the 
stressor), the effects of the endproducts of the stress response and individual 
differences (genetical factors and experience) results in very specific effects of the 
stress response. Identifying individual differences in stress responses in addition to 
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stressor-specific pathways in brain may be essential for understanding and 
treatment of the pathogenesis of stress-related disorders. 
 
In response to stress, activation of the autonomic nervous system and the HPA 
axis will subsequently lead to behavioural, physiological and neurobiological 
adaptations. Initially the stress response will lead to an increase in sympathetic 
nervous activity. This sympathetic activity results in an increased release of 
adrenaline (from the adrenal medulla) and noradrenaline (from other sympathetic 
nerve endings throughout the body) into the bloodstream. These catecholamines 
stimulate the heart and increase the blood flow to the central nervous system and 
muscles within seconds, allowing the organism to directly respond to the stressor 
by vigilance, arousal, and activation. Activation of the HPA axis results in the 
secretion of glucocorticoid hormones. Peak levels of these hormones are usually 
achieved 10 to 30 min after the onset of the stress response. The primary action of 
the glucocorticoids is to elevate blood glucose levels. In addition, glucocorticoids 
are very important to suppress the stress response, to mediate recovery from the 
stress response and to prepare for the next encounter. Both the neuroendocrine and 
autonomic systems interact at several levels, and proper functioning of these 
systems is essential for normal adaptation to stress.  
 
In most cases, a brief period of controllable stress can be experienced as 
excitement and may be beneficial to emotion and health. If, however, the stressor is 
chronic or uncontrollable, the HPA axis is activated for a prolonged time period. 
This can lead to a state of hypercorticism and disturbed negative feedback 
function. In particular, overexposure to corticosteroids may result in changes in 
mood and cognition by affecting neurotransmitter systems such as the serotonergic 
(5-HT) system. In humans, stress is regarded as an important risk factor for the 
development of depression. Depression is often associated with disturbances in 5-
HT system and HPA system. Therefore, this thesis will primarily focus on 
functioning of the HPA axis and 5-HT system during stress and their possible role 
in stress-related mood disorders. The interaction between stress, the HPA axis and 
the 5-HT system as well as stress-related psychopathologies and in particular 
depression is explained in the following paragraphs.  
 
 
2.1. The HPA axis 
 
2.1.1. Description and function of the HPA axis 
 
The HPA axis is activated during stress but it also coordinates circadian events, 
such as food intake and the sleep/wake cycle. This diurnal activity of the HPA axis 
results in a peak of glucocorticoid hormone secretion at the onset of the active 
period (which is the dark period in night active animals). When the HPA axis is 
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activated during stress or around the circadian peak, corticotropin-releasing 
hormone (CRH) is produced in neurons within the paraventricular nucleus (PVN) 
of the hypothalamus. CRH stimulates the anterior pituitary to release 
adrenocorticotropic hormone (ACTH) into the bloodstream. In the adrenal cortex, 
ACTH is bound to its receptors and this stimulates the synthesis of glucocorticoids 
(cortisol in humans, corticosterone in rodents) from cholesterol and increases the 
subsequent secretion of these steroids into the systemic circulation (Fig. 1).  
 
 











Schematic representation of 
the hypothalamus-pituitary-
adrenal (HPA) axis. Bold 
arrows indicate the hormonal 
cascade that triggers the 
release of corticosterone from 
the adrenal glands. Dashed 
arrows represent the feedback 
actions of corticosterone on 
the level of the pituitary and 
PVN which involves GR 
activation (negative feedback) 
and at the level of the 
hippocampus (negative and/or 
positive feedback) which can 
be a synergistic activity of 
colocalized MRs and GRs in 







For many years, it was believed that these glucocorticoid hormones mainly 
acted at the level of the peripheral nervous system via binding to intracellular 
glucocorticoid receptors (GRs) which are found in most peripheral organs. 
However, this idea was completely changed since the discovery of receptors for 
stress hormones within the brain (McEwen et al., 1968). Glucocorticoids easily 
enter the brain due to their lipophilic nature. Here they can bind to 
mineralocorticoid receptors (MRs) in addition to GRs (De Kloet and Reul, 1987). 
MRs are also present in the kidney regulating the salt and water balance of the 
organism by binding aldosterone rather than glucocorticoid hormone. In contrast 
with the brain, glucocorticoids in the kidney are metabolically inactivated by the 
presence of 11beta-hydroxysteroid dehydrogenase (11β-HSD) type 2.  
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The MR and GR differ in their distribution in the brain and in their affinity for 
corticosteroids. The MR is restricted to ‘limbic’ brain structures (hippocampus, 
amygdala and septum), whereas the GR has a widespread distribution, and is 
abundantly expressed in brain regions involved in the stress response such as the 
hypothalamus, hippocampus, amygdala, various brain stem nuclei and pituitary 
(Van Eekelen, 1988; Chao, 1989). MRs have a high affinity for corticosterone, 
approximately 10-fold higher than GRs (Reul and De Kloet, 1985). As a 
consequence, MRs are predominantly occupied at low corticosterone levels (during 
basal trough), whereas additionally GRs will become occupied when corticosterone 
levels are high around the circadian peak and during stress (Reul and De Kloet, 
1985, Reul et al., 1987). This differential affinity for corticosterone in addition to 
the differential distribution of the two receptors may indicate that corticosterone 
has differential functions after binding to the MR or GR. MRs determine the 
sensitivity of the HPA response and are thought to be involved in evaluating of 
environmental stimuli, preparing the organism for a certain behavioural response in 
order to limit homeostatic disturbance as much as possible (De Kloet et al., 1993, 
1998). Activation of GRs (always in addition to already activated MRs) is needed 
for the termination of the HPA response, to mediate recovery from stress, to 
facilitate behavioural adaptation, and to prepare to following stressors (De Kloet et 
al., 1993, 1998). 
 
 
2.1.2. Mechanism of corticosteroid action 
 
When corticosteroid hormones enter the brain they can pass the cell membrane 
and bind to MRs and GRs localized in the cytoplasm. These steroid-receptor 
complexes are then translocated from the cytosol to the nucleus where they bind as 
dimers to specific DNA sequences and act as transcription factors. This results in 
enhancement or repression of gene transcription and thus in alterations in protein 
synthesis. The highest density of MRs and GRs is found in the hippocampus, 
where these receptors are colocalized and can form heterodimers in addition to 
homodimers (Trapp, 1994). The hippocampus (see Fig. 2 for anatomical structure) 
is involved in functions such as mood, cognition and behaviour (Isaacson, 1974). 
Thus both the MR and GR in the hippocampus may play a critical role in these 
functions as well. Indeed, a variety of research findings confirmed the impact of 
hippocampal MR and GR actions on neuroendocrine regulation (Jacobson and 
Sapolsky, 1991; Dallman et al., 1992), neuronal function (Joëls and de Kloet, 
1992a, 1994), neuronal plasticity (McEwen, 1994; Magarinos, 1996), cognition 
(Oitzl and de Kloet, 1992; De Kloet et al., 1999) and recently also hippocampal 
neurogenesis (Gould et al., 1997; Gass et al., 2000). Thus, actions mediated by MR 
and GR in hippocampal neurons appear to be critical for neuronal functioning. This 
has led to the hypothesis that a “balance in hippocampal MR- and GR-mediated 
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effects exerted by corticosteroids is critical for homeostatic control” (De Kloet, 
1991; De Kloet et al., 1998). 
 
To prevent the HPA axis from overshooting, negative feedback actions are 
exerted via MR and GR activation at various levels within the HPA axis. In 
response to high levels of glucocorticoids (around the circadian peak and during 
stress) synergistic activation of both MRs and GRs leads to a suppression of the 
HPA axis (Ratka et al., 1989; Bradbury et al., 1994). At the hypothalamic and 
pituitary level, GR occupation leads to inhibition of HPA activity by suppressing 
the transcripts of genes encoding CRH and ACTH, respectively (De Kloet and 
Reul, 1987; Meaney et al., 1991; De Kloet et al., 1998). At the level of the 
hippocampus, MR activation exerts a tonic inhibitory control on the HPA axis 
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psychiatric disorders, affecting the lives of approximately 10-15% of the 
population, and leading to great personal and social costs. Although the precise 
mechanism by which stress precipitates depression is not clear, the HPA axis and 
the 5-HT system seem to be involved. The abnormalities in the HPA axis of 
depressed patients together with the delay in therapeutic effects of antidepressants 
have led to the hypothesis that antidepressants may act primarily through 
normalisation of the HPA system (for review see Holsboer and Barden, 1996).  
 
Abnormalities in the HPA axis, seen in about half of the patients suffering 
from major depression, include increased concentrations of cortisol in plasma, 
urine, and cerobrospinal fluid (CSF), an increased cortisol response to ACTH, and 
enlargements of pituitary and adrenal glands (Gold et al., 1988; Owens and 
Nemeroff, 1993; Holsboer and Barden, 1996; Nemeroff, 1996). In addition, an 
increase in CRH in the CSF, increased CRH mRNA and protein in the PVN, and a 
blunted ACTH response to CRH have been reported in depressed patients (Gold et 
al., 1988; Nemeroff, 1996). Finally, depressed patients showed non-suppression of 
cortisol and ACTH secretion following administration of the synthetic 
glucocorticoid dexamethasone (dexamethasone suppression test) or in response to 
CRH following dexamethasone pretreatment (Dex/CRH test) (Owens and 
Nemeroff, 1993; Heuser et al., 1994; Holsboer and Barden, 1996; Nemeroff, 
1996). This latter phenomenon is thought to be induced by diminished functioning 
of the corticosteroid receptors in brain and pituitary (De Kloet et al., 1998; 
Holsboer, 2000; Reul et al., 2000). Thus, depressed patients show 
hypercortisolism, increased CRH activity, and impaired glucocorticoid-mediated 
feedback inhibition.  
 
These HPA alterations are thought to play a causal role in the pathogenesis of 
depression. Successful antidepressant treatment of patients with major depression 
was found to be associated with normalization of HPA axis activity (Linkowski et 
al., 1987; Wodarz et al., 1992; Heuser et al., 1996; Deuschle et al., 1997). This 
effect may have been mediated by an increase in corticosteroid receptor function. 
Indeed, an up-regulation of GR mRNA and protein was found in several animal 
studies after long-term treatment with antidepressants (Brady et al., 1992; Pepin et 
al., 1992a; Seckl and Fink, 1992; Przegalinski and Budziszewska, 1993; Reul et al., 
1993; Peeters et al., 1994; Rossby et al., 1995). Chronic antidepressant treatment 
was also found to attenuate several endocrine (elevated levels of corticosterone and 
ACTH) and behavioural abnormalities (cognitive impairment) in transgenic mice 
with a reduced GR expression (Pepin et al., 1992b; Montkowski et al., 1995). In 
addition to GR, MR dysregulation may also contribute to the increased HPA 
activity found in depressed patients (Reul et al., 2000). Reduced levels of MR were 
found in the hippocampi of suicide victims (Lopez et al., 1998). Furthermore, MR 
antagonist studies revealed that a decrease in hippocampal MR functioning leads to 
increased activity of the HPA axis (Oitzl et al., 1994; Heuser et al., 2000). In 
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addition, rats that were chronically stressed showed a decrease in MR gene 
expression, which could be prevented by treatment with the tricyclic antidepressant 
desipramine (Lopez et al., 1998). Other studies showed an up-regulation of the MR 
after chronic treatment with antidepressants (Reul et al., 1993, 1994; Seckl and 
Fink, 1992; Yau et al., 1995). Thus, a balance in MR- and GR-mediated effects on 
the HPA system is of crucial importance to restrain HPA activity (De Kloet et al., 
1998).  
 
As the time course of antidepressant actions on corticosteroid receptors 
coincide with normalization of HPA activity, and follows closely clinical 
improvement of depression (Reul et al., 1993, 1994), it was hypothesized that 
antidepressants may elevate mood in depressed patients through their effects on 
corticosteroid receptors (Barden et al., 1995). The primary action of 
antidepressants could be stimulation of corticosteroid receptor gene expression and 
thereby normalization of the HPA system (Barden et al., 1995). The mechanism by 
which corticosteroids affect mood in depression is, however, not well understood, 
although it is likely that this involves an interaction between corticosteroids and 
neurotransmitter systems such as the 5-HT system.  
 
How the HPA alterations observed in human depression are being developed is 
far from clear. A complex interaction between genetic background and 
environmental factors are thought to determine the susceptibility for depression. In 
particular alterations in the GR gene or GR-regulated genes are thought to 
contribute to a genetic susceptibility for depression. In this light, the data from the 
Munich Vulnerability Study are of interest as they show that about 20% of the 
subjects who never suffered from a psychiatric disorder, but belong to families 
with high genetic load for depression display abnormal responses to the Dex/CRH 
test, suggesting impaired corticosteroid receptor functioning (Holsboer et al., 1995; 
Modell et al., 1998). Recently, it has been proposed that a hyperactive CRH system 
in addition to a dysfunctioning of corticosteroid receptors may underly the HPA 
abnormalities seen in depressed patients (Reul and Holsboer, 2002). 
Hypersecretion of glucocorticoids, induced by impaired glucocorticoid feedback 
inhibition, may lead to an increase in the synthesis of CRH in the central amygdala 
(CRH in this region is under positive control of glucocorticoids [Schulkin et al., 
1998]). This may result in enhanced input from the central amygdala to the PVN, 
where it has a stimulatory influence on the HPA axis (Reul et al., 2000). In such a 
way, a positive feed-forward loop may develop between the amygdala and the 
PVN, resulting in a sustained hyperactivity of the HPA axis (Reul and Holsboer, 
2002).  
 
The recently discovered endogenous ligands besides CRH, which are urocortin 
I, II, and III (Vaughan et al., 1995; Bittencourt et al., 1999; Reyes et al., 2001; Hsu 
and Hsueh, 2001; Lewis et al., 2001), and the presence of two types of CRH 
16        Chapter 1 
receptors (Chalmers et al., 1995), may give new insides in the involvement of the 
CRH family in the stress response and in stress-related psychopathologies (see 
Reul and Holsboer, 2002). Activation of the type 1 CRH receptor by CRH, is 
essential for the acute phase of the stress response, whereas activation of the type 2 
CRH receptor by urocortin II and III, mediates the stress-coping or stress-recovery 
responses (Hsu and Hsueh, 2001). Although more knowledge is required, both the 
CRH system and the corticosteroid receptors are interesting targets for the 
development of novel antidepressant drugs.  
 
The question still remains when corticosteroid hormones, that normally ensure 
survival during a period of stress, become damaging to health. In addition, it is 
unclear why stressful life events may precipitate a depressive episode in some 
subjects and not in others. It is likely that a complex interplay between genetic 
susceptibility and environmental conditions determine the risk of developing 
depression or other stress-related disorders. Understanding the individual 
differences in adaptive responses to stress is the topic of this thesis and may help to 
find clues in the relationship between stress and depressive illness.  
 
 
2.2. The brain serotonin system 
 
2.2.1. Description and function of the serotonin system 
 
Serotonin (5-hydroxytryptamine or 5-HT) is a bioamine synthesized from the 
amino acid tryptophan and acts as a neurotransmitter in the brain. The cell bodies 
containing 5-HT are found in nine clusters located in midbrain, pons and medulla. 
Two clusters are the dorsal raphe and medial raphe nuclei (DRN and MRN, 
respectively) located in the midbrain, which have axonal projections to the 
forebrain, although they appear to have different functions. The widespread 
anatomical distribution of serotonergic neurons throughout the brain is shown in 
Figure 3.  
 
Serotonin produces its effects through a high variety of membrane bound 
receptors (up till now there are 15 different types discovered). All 5-HT receptors 
(in classes of 5-HT1 through 5-HT7) are G-protein-coupled receptors, except for 
the 5-HT3 receptor which is a ligand-gated ion channel. The 5-HT1 receptor 
family contains five receptor subtypes, of which the 5-HT1A receptors are widely 
distributed throughout the brain. In the raphe nuclei, the 5-HT1A receptors are 
somatodendritic, and act as autoreceptors to inhibit cell firing of raphe serotonergic 
cells. Postsynaptic 5-HT1A receptors can be found in a number of limbic structures. 
The 5-HT1A receptors are linked to G-protein cAMP second messenger systems 
which regulates K+ channels. Activation of 5-HT1A receptors causes neuronal 
hyperpolarization, leading in general to suppressed activity of the neurons. 
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Schweitzer, 1990; Fabre, 1990; Robinson et al., 1990; Den Boer et al., 2000). This 
role of 5-HT1A receptor in anxiety and depression was recently supported by 
studies utilising 5-HT1A receptor knockout mice. These mice showed an increase in 
anxiety- and depression-related behaviours (Heisler et al., 1998; Parks et al., 1998). 
During the past decade it is, however, questioned whether 5-HT deficiency is a 
cause or a consequence of depression. The time course of antidepressant action in 
addition to HPA alterations seen in depressed patients have led to the hypothesis 
that antidepressants might elevate mood by primarily acting on the HPA axis. 
Although the precise mechanism of antidepressant action is still unclear, it is 
known that the HPA axis and the 5-HT system interact at numerous levels, and that 
proper functioning of both systems is required for stress adaptation. 
 
 
2.3. Interactions between the HPA and serotonin systems 
 
The serotonergic system can interact with the HPA axis in a bidirectional way. 
Serotonin can have effects on several components of the HPA axis. Serotonergic 
neurons projecting from the raphe nuclei form synapses with CRH-containing 
neurons in the PVN (Fuller, 1990) and can thereby influence the release of CRH, 
ACTH and corticosterone (Fuller, 1990; Fuller and Snoddy, 1990; Van de Kar 
1991). Furthermore, the 5-HT1A receptor appears to mediate activation of the HPA 
axis (Fuller 1990; Jorgensen et al., 2002).  
Serotonergic neurotransmission can also be modulated by corticosteroids. The 
stress-induced 5-HT synthesis rate can be reduced by removal of the adrenal glands 
(adrenalectomy), while corticosterone replacement normalizes this 5-HT response 
(De Kloet et al., 1982; Singh et al., 1990; Korte-Bouws et al., 1996). This effect of 
corticosterone is probably mediated by GR activation in the hippocampus which is 
projecting to the raphe nuclei (Singh et al., 1990; Linthorst et al., 1995). In 
particular in the hippocampus, interactions occur between the 5-HT1A receptor (the 
most abundant serotonin receptor in this region) and colocalized MR and GR (Joëls 
et al., 1991). Adrenalectomy induced an increase in hippocampal 5-HT1A receptor 
gene expression in particular in the dentate gyrus (De Kloet et al., 1986; Chalmers 
et al., 1993), which could be prevented by administration of low levels of 
corticosterone (Chalmers et al., 1993). Additionally, electrophysiological studies 
have shown that 5-HT-induced hyperpolarization in CA1 and dentate gyrus 
hippocampal neurons was suppressed by predominant activation of MRs (Joëls et 
al., 1991). Thus, hippocampal 5-HT1A receptor expression and functioning is under 
tonic inhibition of corticosterone when the hormone predominantly activates MRs 
(Meijer and de Kloet, 1995).  
By contrast, higher concentrations of corticosterone resulting in combined 
occupation of MR and GR were found to overrule the MR effects and induced a 
large 5-HT1A receptor-mediated hyperpolarization (Joëls and de Kloet, 1992b). 
When corticosterone levels are chronically elevated, either pharmacologically or 
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due to chronic stress, hippocampal 5-HT1A receptor binding and gene expression 
was down-regulated (Watanabe et al., 1993; Meijer et al., 1997; Lopez et al., 1998; 
Veenema, unpublished observation) and 5-HT1A receptor responsiveness was 
decreased (Karten et al., 1999). This effect may have been mediated by over-
activation of MRs (Meijer et al., 1997). Meijer and colleagues (1997) showed that 
flattening of the diurnal corticosterone rhythm (by elevated basal trough levels), 
resulting in predominant MR activation, induced a similar decrease in hippocampal 
in 5-HT1A receptor expression and binding. Corticosteroids had no effect on 
presynaptic 5-HT1A receptor gene expression in the dorsal raphe nucleus (Chalmers 
et al., 1993). This suggests that the activity of the hippocampal 5-HT system can be 
modulated by MR (tonic inhibition) and GR (facilitation) and that a balanced 
activation between MR and GR is important for normal 5-HT1A receptor function. 
 
 
3. Individual susceptibility to stressors 
 
The way individuals cope with stressful situations shows a high variability in 
behavioural responses. Extensive research has shown that at least two alternative 
behavioural strategies to cope with environmental stimuli can be distinguished in 
several species including mice, rats, birds, pigs, monkeys and humans (Benus et 
al., 1991a; Crusio et al., 1991; Hinton et al., 1991; Ursin et al., 1993; Koolhaas et 
al., 1999). One is the ‘active’ coping style (or fight-flight) and the other is the 
‘passive’ coping style (or conservation-withdrawal). These alternative behavioural 
strategies are accompanied by differences in neuroendocrine and physiological 
responses. Active coping is associated with higher sympatho-adrenal activity and 
lower HPA reactivity, whereas passive coping is characterised by predominant 
parasympathetic activity and higher HPA reactivity (Bohus et al., 1987, 1993; 
Koolhaas, 1994; Sgiofo et al., 1996; Korte et al., 1997, 1999). Both coping styles 
have a distinct adaptive value and may be important for the survival of the species 
by regulation of the population. This is supported by the finding that in wildlife 
rodent populations, both the active and passive behavioural coping styles are 
encountered at a higher rate than expected by chance (Bohus et al., 1987; Koolhaas 
et al., 1999). The main difference between the two coping strategies is likely the 
degree of behavioural plasticity or flexibility (Koolhaas et al., 2001). This may 
have implications for a differential susceptibility for stress-related diseases. Two 
selected lines of wild house mice were used as animal model tot test for individual 
differences in stressor susceptibility. This thesis will focus on differences in 
baseline and stress-induced activity and functioning of the HPA and 5-HT systems 
in the two mouse lines that show distinctly different behavioural coping strategies. 
These selection lines will be introduced in the next paragraph. 
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3.1. Genetically selected mouse lines 
 
Male mice, originating from a colony of wild house-mice (Mus musculus 
domesticus) maintained at the University of Groningen, The Netherlands, have 
been selected for long attack latency (LAL) and short attack latency (SAL). The 
original colony descended from four males and three females caught from the wild 
in 1971. Until 1973, the mice were bred at random after which selection for attack 
latency started with 21 males and 21 females (see Fig. 4). All young adult males 
(92-100 days of age) are tested for their attack latency (Van Oortmerssen and 
Bakker, 1981). In this test, LAL and SAL males are confronted with a standard 
non-aggressive opponent male of an inbred albino strain (MAS-Gro) at the border 
of their home cage. The time it takes before a LAL or SAL mouse attacks the non-
aggressive opponent (with a maximum duration of 600 s) is measured on three 













































Fig. 4. Genetic selection for long attack latency (LAL, dashed line) and short attack latency 
(SAL, solid line) in males of wild house-mice. Several attempts were necessary to 
successfully breed low-aggressive LAL males. At present, SAL males have an attack 
latency score of less than 50 s, and most LAL males do not attack within the experimental 
time (which is 3 × 600 s).  
General introduction        21 
Besides their differences in attack latency, the LAL and SAL mice show 
profound differences in their behavioural response when exposed to environmental 
challenges (see Table 1). For example, LAL mice suppress their activity when 
exposed to uncontrollable or unescapable stressors (Sluyter et al., 1996), but 
perform very well in a changing environment (Benus et al., 1987). SAL mice 
perform better in a two-way shock avoidance (Benus et al., 1989), but show more 
routine-like behaviour in both social and non-social situations (Benus et al., 1988, 
1990). Thus, LAL mice seem to depend more on environmental cues whereas SAL 
mice are more intrinsically controlled. Furthermore, SAL and LAL mice differ in 
their response initiation to stressors. LAL mice seem to respond only when 
absolutely necessary, and show a high degree of behavioural flexibility, whereas 
SAL mice respond immediately to a challenge by showing active behaviour. All 
together, it was concluded that LAL males display a ‘passive’ or ‘reactive’ coping 
style when exposed to new environmental stimuli whereas SAL males show an 
‘active’ or ‘proactive’ coping style (Benus et al., 1991a).  
 
 
Table 1. Overview of the behavioural differences between low-aggressive LAL males and 
high-aggressive SAL males. 
 
 
 Behavioural characteristics  LAL    SAL 
 
 Attack latency    Long    Short 
 Active Avoidance   Low    High 
 Defensive burying   Low    High 
 Nest-building    Low    High 
 Routine formation   Low    High 
 Day-night reversal   Fast    Slow 
 Cue dependency    High    Low 
 Conditioned immobility   High    Low 




These behavioural differences in LAL and SAL mice were each associated 
with a specific pattern of neuroendocrine and neurochemical responses (see Table 
2). Hippocampal 5-HT1A receptor transcript and binding was found to be lower in 
LAL mice, which was associated with higher plasma levels of corticosterone 
(Korte et al., 1996). As compared to SAL mice, LAL mice had larger hippocampal 
mossy fibre terminal fields (Sluyter et al., 1994), which is thought to be positively 
related to spatial learning (Prior et al., 1997). During the neonatal period, LAL 
mice are exposed to higher levels of testosterone than SAL mice (Compaan et al., 
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1992; De Ruiter et al., 1992). This may be related to a differential organisation of 
the testosterone dependent vasopressin system. Indeed it was found that the density 
of vasopressinergic (AVP) neurons in the bed nucleus of the stria terminalis and its 
innervation of the lateral septum was higher in LAL mice (Compaan et al., 1993). 
Finally, SAL mice showed higher sensitivity to apomorphine-induced stereotyped 
behaviour (Benus et al., 1991b). Apomorphine acts on the dopaminergic system in 
the striatum, suggesting a difference between LAL and SAL in the sensitivity of 
this system. All together, these data indicate that LAL and SAL mice show a 
distinctly different organisation of the central nervous system, which might 
underlie the opposing behavioural coping styles displayed by the two mouse lines.  
 
 
Table 2. Overview of the neuroendocrine and neurochemical differences between low-
aggressive LAL and high-aggressive SAL males. 
 
 
  LAL    SAL 
 
 Plasma corticosterone   High    Low 
 Hippocampal 5-HT1A receptor  Low    High 
 Hippocampal mossy fibres  Large    Small 
 Septum AVP-ir fibre density  Low    High 




In view of the profound differences in behavioural traits as well as differences 
in corticosterone and 5-HT1A receptor, the LAL and SAL mice present an 
interesting animal model to study whether these differences are paralleled by 




4. Aim of the thesis 
 
The relationship between alterations in the HPA and 5-HT systems and 
depressive behaviour is poorly understood, as well as how some individuals are 
more likely to develop depression than others under seemingly similar conditions. 
Understanding the individual differences in adaptive responses to stress may help 
to understand the relationship between stress and depressive illness. This thesis 
will study the ability to cope with different stressors in long (LAL) and short 
(SAL) attack latency mice at various levels of the HPA axis and 5-HT system. 
These two mouse lines are thought to represent the extremes of the two 
behavioural strategies (‘passive’ vs. ‘active’ coping style) which exist in normal 
populations of animals as well as man.  
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We hypothesize that this difference in behavioural coping style is associated 
with a differential response to stressors and, as a consequence, differential stressor 
susceptibility. 
 
The aims of this thesis are: 
 
i. To test the hypothesis that a difference in behavioural coping style is 
associated with a differential HPA and 5-HT functioning and hippocampal 
plasticity under basal and acute stress conditions 
 
ii. To determine whether genetic selection for coping style is associated with 
a differential susceptibility to chronic stressors and whether this is 




4.1 Experimental approach 
 
LAL and SAL mice will be examined under baseline conditions and after acute 
stress in their response of markers of the HPA system and the 5-HT system. 
Exposure to a psychosocial stressor (sensory contact model) will be used as a 
model to investigate the ability of the mice to cope with a chronic stressor and to 
initiate changes which are also observed in human depression, namely: increased 
HPA activity, imbalance of hippocampal MR and GR and reduced expression of 
hippocampal 5-HT1A receptor. Finally, the effect of stress on hippocampal 
plasticity (by measuring hippocampal neurogenesis) was determined in LAL and 
SAL mice.  
 
 
4.2 Outline of the thesis 
 
In chapter 2, the two mouse lines are characterized for their neuroendocrine 
response pattern under basal and acute stress conditions to investigate whether a 
difference at a behavioural level is associated with a difference in HPA activity. 
Corticosterone and ACTH were measured at various time points to assess basal 
HPA activity during the light and dark phase. HPA reactivity was assessed by 
exposing the mice to an acute stressor (forced swimming for 5 min.). The mRNA 
expression of hypothalamic CRH and of hippocampal MR and GR was determined 
under basal and acute stress conditions.  
 
In chapter 3, the capacity of LAL and SAL mice to cope with different 
chronic psychosocial stressors was studied. For this purpose, the sensory contact 
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model was used in which a male mouse (LAL or SAL) was continuously living 
opposite an aggressive (SAL) male for 25 days. One group of mice was 
additionally defeated by the SAL opponent for 21 consecutive days. Line- and 
stressor-specific differences on several physiological, neuroendocrine and 
behavioural parameters are described.   
 
In chapter 4 it was hypothesized that the differential response of LAL and 
SAL mice to sensory contact stress was already present after a period of 5 days. 
Furthermore, the effect of type of opponent in the sensory contact model on this 
differential response was investigated. Therefore, a LAL or SAL male was 
continuously living opposite a SAL male, opposite a LAL male, or single. Line- 
and stressor-specific differences on several physiological, neuroendocrine and 
behavioural parameters are described. 
 
Chapter 5 describes baseline and acute stress-induced differences in 
hippocampal cell proliferation rate in LAL and SAL mice, and the possible 
involvement of HPA hormones. 
 
In chapter 6 differences between LAL and SAL mice are described at the level 
of 5HT1A receptor expression and binding capacity and brain 5-HT turnover. The 
behavioural effect of two 5-HT1A receptor agonists (8-OH-DPAT and S-15535) 
were study in LAL and SAL mice in the forced swim test. Finally, the effect of 8-
OH-DPAT and S-15535 was determined on stress-induced 5-HT and 5-HIAA 
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